vx-745 has been researched along with quinazolines in 3 studies
Studies (vx-745) | Trials (vx-745) | Recent Studies (post-2010) (vx-745) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
---|---|---|---|---|---|
58 | 1 | 35 | 19,235 | 2,417 | 8,835 |
Protein | Taxonomy | vx-745 (IC50) | quinazolines (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, JW; Cameron, PM; Fitzgerald, CE; O'Keefe, SJ; Patel, SB; Pikounis, VB; Scapin, G; Zaller, D | 1 |
Laufer, S; Wagner, G | 1 |
Natarajan, SR; O'Keefe, SJ; O'Neill, EA; Thompson, JE; Wisnoski, DD | 1 |
1 review(s) available for vx-745 and quinazolines
Article | Year |
---|---|
Small molecular anti-cytokine agents.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Caspase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytokines; Humans; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Structure-Activity Relationship; Succinates; Thiazoles; Tumor Necrosis Factor-alpha; Urea | 2006 |
2 other study(ies) available for vx-745 and quinazolines
Article | Year |
---|---|
Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity.
Topics: Amino Acid Sequence; Animals; Cloning, Molecular; Enzyme Inhibitors; Glycine; Imidazoles; Inhibitory Concentration 50; Kinetics; Mice; Mitogen-Activated Protein Kinase 14; Mitogen-Activated Protein Kinases; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutation; Peptides; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Sequence Homology, Amino Acid | 2003 |
p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones.
Topics: Chemistry, Pharmaceutical; Drug Design; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Models, Chemical; p38 Mitogen-Activated Protein Kinases; Pyridazines; Pyridines; Pyrimidines; Pyrimidinones; Quinazolines; Structure-Activity Relationship | 2006 |